|
PAPD4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.61453139325386E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72406533494041E-12 |
| Normal-vs-Stage2 |
1.209960E-04 |
| Normal-vs-Stage3 |
3.83649999999847E-05 |
| Normal-vs-Stage4 |
2.007500E-04 |
| Stage1-vs-Stage2 |
7.014600E-01 |
| Stage1-vs-Stage3 |
5.082300E-02 |
| Stage1-vs-Stage4 |
1.066380E-02 |
| Stage2-vs-Stage3 |
1.387820E-01 |
| Stage2-vs-Stage4 |
7.550100E-02 |
| Stage3-vs-Stage4 |
6.505200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.34001706900244E-12 |
| Normal-vs-AfricanAmerican |
5.72909999999593E-05 |
| Normal-vs-Asian |
4.890500E-02 |
| Caucasian-vs-AfricanAmerican |
9.802000E-01 |
| Caucasian-vs-Asian |
3.389600E-01 |
| AfricanAmerican-vs-Asian |
3.057800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.10165259931728E-12 |
| Normal-vs-Female |
3.98510002774799E-10 |
| Male-vs-Female |
9.445400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.836300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.24780202731745E-11 |
| Normal-vs-Age(61-80Yrs) |
3.78079789697949E-11 |
| Normal-vs-Age(81-100Yrs) |
2.683900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.302000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.447200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.683200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.434000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.195800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.393600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.815600E-03 |
| Normal-vs-Grade 2 |
5.45119505090952E-14 |
| Normal-vs-Grade 3 |
2.95409996464713E-09 |
| Normal-vs-Grade 4 |
3.037800E-02 |
| Grade 1-vs-Grade 2 |
9.159800E-01 |
| Grade 1-vs-Grade 3 |
2.879600E-01 |
| Grade 1-vs-Grade 4 |
2.874100E-02 |
| Grade 2-vs-Grade 3 |
1.969980E-02 |
| Grade 2-vs-Grade 4 |
5.87450000000267E-05 |
| Grade 3-vs-Grade 4 |
2.275600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62825308791525E-12 |
| Normal-vs-ccB subtype |
6.62689999986199E-07 |
| ccA subtype-vs-ccB subtype |
3.100200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.62649910101709E-11 |
| Normal-vs-N1 |
2.039400E-01 |
| N0-vs-N1 |
3.532000E-01 |
|
|
